000 | 01819 a2200517 4500 | ||
---|---|---|---|
005 | 20250513194925.0 | ||
264 | 0 | _c20000110 | |
008 | 200001s 0 0 eng d | ||
022 | _a0022-1899 | ||
024 | 7 |
_a10.1086/315136 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNielsen, S D | |
245 | 0 | 0 |
_aTreatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected persons. _h[electronic resource] |
260 |
_bThe Journal of infectious diseases _cDec 1999 |
||
300 |
_a1819-26 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, CD34 _xanalysis |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aFilgrastim |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 | _aHIV-1 |
650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aOrgan Culture Techniques |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aT-Lymphocytes _xphysiology |
650 | 0 | 4 |
_aThymus Gland _ximmunology |
700 | 1 | _aClark, D R | |
700 | 1 | _aHutchings, M | |
700 | 1 | _aDam-Larsen, S | |
700 | 1 | _aRepping, S | |
700 | 1 | _aNielsen, J O | |
700 | 1 | _aMathiesen, L | |
700 | 1 | _aMiedema, F | |
700 | 1 | _aHansen, J E | |
773 | 0 |
_tThe Journal of infectious diseases _gvol. 180 _gno. 6 _gp. 1819-26 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1086/315136 _zAvailable from publisher's website |
999 |
_c10515280 _d10515280 |